ACR Meeting Abstracts

ACR Meeting Abstracts

  • Home
  • Meetings Archive
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018 ACR/ARHP Annual Meeting
    • 2017 ACR/ARHP Annual Meeting
    • 2017 ACR/ARHP PRSYM
    • 2016-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • Register
    • View and print all favorites
    • Clear all your favorites
  • Meeting Resource Center

Abstract Number: 2318

Elevated Pro-inflammatory Lipid Mediators Associate with Low Paraoxonase 1 Activity in Patients with Rheumatoid Arthritis and Arthritic K/BxN Mice

Christina Charles-Schoeman1, Jennifer Wang 2, Ani Shahbazian 2, Jeremy Papesh 2 and Srinivasa Reddy 2, 1University of California, Los Angeles, CA, 2UCLA Medical Center, Los Angeles

Meeting: 2019 ACR/ARP Annual Meeting

Keywords: arteriosclerosis and rheumatoid arthritis (RA)

  • Tweet
  • Email
  • Print
Save to PDF
Session Information

Date: Tuesday, November 12, 2019

Session Title: RA – Diagnosis, Manifestations, & Outcomes Poster III: Comorbidities

Session Type: Poster Session (Tuesday)

Session Time: 9:00AM-11:00AM

Background/Purpose: Paraoxonase 1 (PON1) is a high density lipoprotein (HDL)-associated enzyme, which promotes the anti-oxidant and anti-inflammatory properties of HDL. We previously associated low PON1 activity with increased atherosclerotic risk in patients with rheumatoid arthritis (RA). The current work investigates the relationship of PON1 activity to a lipidomics panel of pro-inflammatory bioactive lipid mediators (BLM) in patients with RA and arthritic K/BxN mice.

Methods: Group A included 16 RA patients with carotid atherosclerosis (RA-ATH), 16 RA patients without carotid ATH (RA), and 16 healthy controls (HC). Group B included 29 arthritic K/BxN mice, (9 weeks (n=10), 14 weeks (n=12), 21 weeks (n=7)), and 21 non-arthritic control mice, (14 weeks, KRN (n=10), Ag7 (n= 11)). Circulating PON1 activity was measured using 3 different substrates: phenylacetate (arylesterase assay), dihydrocoumarin (lactonase assay), and paraoxon (paraoxonase assay). Liquid chromatography–electrospray ionization, tandem mass spectroscopy was performed for a panel of 10 circulating BLM including TXB2, 13 HODE, 9 HODE, 17S-HDHA, 15 HETE, 14 S-HDHA, 11 HETE, 12 HETE, 5 HETE, and 5-oxoETE.  

Results: PON1 activity was lower in patients with RA compared to HC and was significantly lower in the RA-ATH group compared to the RA group by both paraoxonase and lactonase assays. Similarly, PON1 activity was lower in arthritic K/BxN mice compared to KRN/Ag7 non-arthritic controls. Multiple BLMs were elevated in RA patients and K/BxN mice compared to controls, with trends for highest levels in the RA-ATH group compared to RA and HC groups (Table 1). Lower PON1 activity by arylesterase and lactonase assays correlated with higher levels of several BLMs in both humans and mice (Table 2).

Conclusion: Low circulating activity of the HDL-associated enzyme PON1 associates with higher pro-inflammatory BLMs in both RA patients and arthritic K/BxN mice. This work suggests a potential mechanism for increase atherosclerotic risk in patients with active RA via suppression of PON1 activity and elevation in pro-inflammatory lipid mediators. Further work is warranted to determine if PON1 represents a potential “dual” therapeutic target in patients with RA.


Lipidomics abstract Table 1 6-3-19.3

Values are mean ± SD. Units are ng/ml for all BLMs. *p<0.05 compared to HC or Ag7/KRN. # p<0.05 compared to RA-ATH.


Lipidomics Abstract Table 2 6-3-19.3

*p<0.05, # p ≤ 0.1 for Spearman correlation coefficient.


Disclosure: C. Charles-Schoeman, Abbvie, 2, AbbVie, 2, Amgen, 5, BMS, 2, Bristol Myers Squibb, 2, Gilead, 5, Octapharma, 2, 5, Pfizer, 2, 5, Regeneron, 5, Regeneron/Sanofi, 5, Sanofi, 5; J. Wang, None; A. Shahbazian, None; J. Papesh, None; S. Reddy, None.

To cite this abstract in AMA style:

Charles-Schoeman C, Wang J, Shahbazian A, Papesh J, Reddy S. Elevated Pro-inflammatory Lipid Mediators Associate with Low Paraoxonase 1 Activity in Patients with Rheumatoid Arthritis and Arthritic K/BxN Mice [abstract]. Arthritis Rheumatol. 2019; 71 (suppl 10). https://acrabstracts.org/abstract/elevated-pro-inflammatory-lipid-mediators-associate-with-low-paraoxonase-1-activity-in-patients-with-rheumatoid-arthritis-and-arthritic-k-bxn-mice/. Accessed January 16, 2021.
  • Tweet
  • Email
  • Print
Save to PDF

« Back to 2019 ACR/ARP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/elevated-pro-inflammatory-lipid-mediators-associate-with-low-paraoxonase-1-activity-in-patients-with-rheumatoid-arthritis-and-arthritic-k-bxn-mice/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

ACR Convergence: Where Rheumatology Meets. All Virtual. November 5-9.

ACR Pediatric Rheumatology Symposium 2020

© COPYRIGHT 2021 AMERICAN COLLEGE OF RHEUMATOLOGY

Wiley

  • Home
  • Meetings Archive
  • Advanced Search
  • Meeting Resource Center
  • Online Journal
  • Privacy Policy
  • Permissions Policies
loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.
This site uses cookies: Find out more.